Silence Therapeutics plc (SLN)

Silence Therapeutics Statistics

Total Valuation

SLN has a market cap or net worth of $310.80 million. The enterprise value is $208.79 million.

Market Cap	310.80M
Enterprise Value	208.79M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

SLN has 47.23 million shares outstanding. The number of shares has increased by 6.92% in one year.

Current Share Class	n/a
Shares Outstanding	47.23M
Shares Change (YoY)	+6.92%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	34.66%
Owned by Institutions (%)	30.84%
Float	24.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.03
Forward PS	n/a
PB Ratio	4.20
P/TBV Ratio	4.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.69, with a Debt / Equity ratio of 0.00.

Current Ratio	7.69
Quick Ratio	7.16
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.18% and return on invested capital (ROIC) is -43.42%.

Return on Equity (ROE)	-64.18%
Return on Assets (ROA)	-23.36%
Return on Invested Capital (ROIC)	-43.42%
Return on Capital Employed (ROCE)	-54.08%
Revenue Per Employee	$222,672
Profits Per Employee	-$556,379
Employee Count	116
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

In the past 12 months, SLN has paid $335,000 in taxes.

Income Tax	335,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.42% in the last 52 weeks. The beta is 1.34, so SLN's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-63.42%
50-Day Moving Average	5.77
200-Day Moving Average	5.03
Relative Strength Index (RSI)	52.83
Average Volume (20 Days)	192,396

Short Selling Information

Short Interest	627,952
Short Previous Month	743,480
Short % of Shares Out	1.33%
Short % of Float	2.52%
Short Ratio (days to cover)	6.41

Income Statement

In the last 12 months, SLN had revenue of $25.83 million and -$64.54 million in losses. Loss per share was -$1.37.

Revenue	25.83M
Gross Profit	23.59M
Operating Income	-69.99M
Pretax Income	-64.21M
Net Income	-64.54M
EBITDA	-69.42M
EBIT	-69.99M
Loss Per Share	-$1.37

Balance Sheet

The company has $102.19 million in cash and $182,000 in debt, giving a net cash position of $102.01 million or $2.16 per share.

Cash & Cash Equivalents	102.19M
Total Debt	182,000
Net Cash	102.01M
Net Cash Per Share	$2.16
Equity (Book Value)	74.06M
Book Value Per Share	1.57
Working Capital	116.25M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 91.32%, with operating and profit margins of -270.95% and -249.86%.

Gross Margin	91.32%
Operating Margin	-270.95%
Pretax Margin	-248.57%
Profit Margin	-249.86%
EBITDA Margin	-268.77%
EBIT Margin	-270.95%
FCF Margin	n/a

Dividends & Yields

SLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.92%
Shareholder Yield	-6.92%
Earnings Yield	-20.77%
FCF Yield	n/a

Analyst Forecast

The average price target for SLN is $39.67, which is 502.89% higher than the current price. The consensus rating is "Buy".

Price Target	$39.67
Price Target Difference	502.89%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2